RUNX1 mutations in pediatric acute myeloid leukemia are associated with distinct genetic features and an inferior prognosis

被引：13

作者：

Yamato, Genki ^{[1
,2
,3
]}

Shiba, Norio ^{[3
,4
]}

Yoshida, Kenichi ^{[5
]}

Hara, Yusuke ^{[2
,3
]}

Shiraishi, Yuichi ^{[6
]}

Ohki, Kentaro ^{[7
]}

Okubo, Jun ^{[1
]}

Park, Myoung-ja ^{[1
]}

Sotomatsu, Manabu ^{[1
]}

Arakawa, Hirokazu ^{[2
]}

Kiyokawa, Nobutaka ^{[7
]}

Tomizawa, Daisuke ^{[8
]}

Adachi, Souichi ^{[9
]}

Taga, Takashi ^{[10
]}

Horibe, Keizo ^{[3
]}

Miyano, Satoru ^{[6
,11
]}

Ogawa, Seishi ^{[5
,12
]}

Hayashi, Yasuhide ^{[1
,3
,13
]}

机构：

[1] Gunma Childrens Med Ctr, Dept Hematol Oncol, 779 Shimohakoda, Shibukawa, Gunma 3778577, Japan

[2] Gunma Univ, Grad Sch Med, Dept Pediat, Gunma, Japan

[3] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan

[4] Yokohama City Univ Med, Dept Pediat, Yokohama, Kanagawa, Japan

[5] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto, Japan

[6] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal, Tokyo, Japan

[7] Natl Res Inst Child Hlth & Dev, Dept Pediat Hematol & Oncol Res, Tokyo, Japan

[8] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Tokyo, Japan

[9] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan

[10] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan

[11] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan

[12] Karolinska Inst, Dept Med, Ctr Hematol & Regenerat Med, Stockholm, Sweden

[13] Japanese Red Cross Gunma Blood Ctr, Gunma, Japan

来源：

BLOOD | 2018年 / 131卷 / 20期

关键词：

DNMT3A MUTATIONS; RELEVANCE; THERAPY; RARE; AML;

D O I：

10.1182/blood-2017-11-814442

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2266 / 2270

页数：7

共 50 条

[31] TdT plus Acute Myeloid Leukemia is enriched for mutations of RUNX1, BCOR, and ASXL1
Bailey, Nathanael
Carlsen, Eric
Wild, Matthew
Liu, Yen-Chun
Djokic, Miroslav
MODERN PATHOLOGY, 2019, 32
[32] RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
Gaidzik, Verena I.
Bullinger, Lars
Schlenk, Richard F.
Zimmermann, Andreas S.
Roeck, Juergen
Paschka, Peter
Corbacioglu, Andrea
Krauter, Juergen
Schlegelberger, Brigitte
Ganser, Arnold
Spaeth, Daniela
Kuendgen, Andrea
Schmidt-Wolf, Ingo G. H.
Goetze, Katharina
Nachbaur, David
Pfreundschuh, Michael
Horst, Heinz A.
Doehner, Hartmut
Doehner, Konstanze
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : 1364 - 1372
[33] Familial Acute Myeloid Leukemia/Myelodysplastic Syndrome with Germline RUNX1 Mutations: A Single Instituion Experience
Hathuc, Vivian
Walkovich, Kelly
Bixby, Dale
Shao, Lina
Smith, Lauren
LABORATORY INVESTIGATION, 2017, 97 : 467A - 467A
[34] Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
Roman Hornung
Vindi Jurinovic
Aarif M. N. Batcha
Stefanos A. Bamopoulos
Maja Rothenberg-Thurley
Susanne Amler
Maria Cristina Sauerland
Wolfgang E. Berdel
Bernhard J. Wörmann
Stefan K. Bohlander
Jan Braess
Wolfgang Hiddemann
Sören Lehmann
Sylvain Mareschal
Karsten Spiekermann
Klaus H. Metzeler
Tobias Herold
Anne-Laure Boulesteix
Scientific Reports, 8
[35] Frequent RUNX1 and TP53 Mutations in Secondary Acute Myeloid Leukemia with Mixed Phenotype
Galera, Pallavi
Baik, Jeeyeon
Famulare, Christopher
Sigler, Allison
Zhang, Yanming
Arcila, Maria
Dogan, Ahmet
Tallman, Martin
Levine, Ross
Glass, Jacob
Roshal, Mikhail
Xiao, Wenbin
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1293 - 1294
[36] Frequency, Characteristics and Prognostic Significance of RUNX1 mutations in Patients with Acute Myeloid Leukemia, Not Otherwise Specified
Bae, Mi-Hyun
Cho, Young-Uk
Kim, Bohyun
Lee, Dong Hyun
Jang, Seongsoo
Seo, Eul-Ju
Park, Chan-Jeoung
Kim, Dae-Young
Lee, Jung-Hee
Lee, Je-Hwan
Lee, Kyoo-Hyung
Chang, Yoon Hwan
Kim, In-Suk
BLOOD, 2015, 126 (23)
[37] Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia
Venugopal, Sangeetha
DiNardo, Courtney D.
Loghavi, Sanam
Qiao, Wei
Ravandi, Farhad
Konopleva, Marina
Kadia, Tapan
Bhalla, Kapil
Jabbour, Elias
Issa, Ghayas C.
Macaron, Walid
Daver, Naval
Borthakur, Gautam
Montalban-Bravo, Guillermo
Yilmaz, Musa
Patel, Keyur P.
Kanagal-Shamanna, Rashmi
Chien, Kelly
Maiti, Abhishek
Kantarjian, Hagop
Short, Nicholas J.
AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (12) : 1560 - 1567
[38] Familial Acute Myeloid Leukemia/Myelodysplastic Syndrome with Germline RUNX1 Mutations: A Single Instituion Experience
Hathuc, Vivian
Walkovich, Kelly
Bixby, Dale
Shao, Lina
Smith, Lauren
MODERN PATHOLOGY, 2017, 30 : 467A - 467A
[39] Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
Hornung, Roman
Jurinovic, Vindi
Batcha, Aarif M. N.
Bamopoulos, Stefanos A.
Rothenberg-Thurley, Maja
Amler, Susanne
Sauerlands, Maria Cristina
Berdel, Wolfgang E.
Woermann, Bernhard J.
Bohlander, Stefan K.
Braess, Jan
Hiddemann, Wolfgang
Lehmann, Soren
Mareschal, Sylvain
Spiekermann, Karsten
Metzeler, Klaus H.
Herold, Tobias
Boulesteix, Anne-Laure
SCIENTIFIC REPORTS, 2018, 8
[40] RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia
Chow, Signy
Tang, Kenny
Al-Abri, Mahmood
Hall, Victoria
Tremblay-Lemay, Rosemarie
Rashedi, Iran
Tsui, Hubert
Chan, Steven M.
LEUKEMIA RESEARCH, 2021, 111

← 1 2 3 4 5 →